PRESS RELEASE published on 03/13/2023 at 13:30, 3 years 5 months ago Jaguar Health Leveraging AI to Support Patient Access to Mytesi, the Company's FDA-Approved Prescription Drug
PRESS RELEASE published on 03/02/2023 at 14:30, 3 years 5 months ago Jaguar Health to Present at BioTrinity 2023 Conference’s R&D Spotlight on Rare Diseases
PRESS RELEASE published on 02/28/2023 at 14:30, 3 years 6 months ago FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication in the US
PRESS RELEASE published on 02/23/2023 at 14:30, 3 years 6 months ago Jaguar Health Receives Notice of Allowance for U.S. Patent for Lead FDA Approved Drug Crofelemer
PRESS RELEASE published on 02/21/2023 at 14:30, 3 years 6 months ago Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 02/09/2023 at 14:30, 3 years 6 months ago Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
PRESS RELEASE published on 02/08/2023 at 14:30, 3 years 6 months ago Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
PRESS RELEASE published on 02/01/2023 at 15:45, 3 years 7 months ago Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
PRESS RELEASE published on 02/01/2023 at 14:30, 3 years 7 months ago Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
PRESS RELEASE published on 01/30/2023 at 14:30, 3 years 7 months ago Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
Published on 09/01/2026 at 23:05, 2 hours 57 minutes ago Aton Announces US$30M Credit Facility with OU Moonrider
Published on 09/01/2026 at 22:30, 3 hours 32 minutes ago Algo Grande Copper Closes Oversubscribed Private Placement for $4.786 Million
Published on 09/01/2026 at 22:15, 3 hours 47 minutes ago NuRAN Wireless Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
Published on 09/01/2026 at 16:10, 9 hours 52 minutes ago Sparton Signs Definitive Morrison Silver Mine Option and Joint Venture Agreement with Glen Eagle; Appoints Vice President, Corporate Development
Published on 09/02/2026 at 01:05, 57 minutes ago Clean electricity supplied 40% of new energy demand in 2025. Faster deployment and sectoral breakthroughs can cut emissions permanently, says annual Energy Transition Monitor
Published on 09/01/2026 at 22:00, 4 hours 2 minutes ago MHM CORPORATE - Publication of unaudited half-year 2026 financial information
Published on 09/01/2026 at 20:07, 5 hours 55 minutes ago EQS-Adhoc: HUGO BOSS AG: HUGO BOSS TERMINATES SHARE BUYBACK PROGRAM
Published on 09/01/2026 at 20:00, 6 hours 2 minutes ago MHM Corporate: announces the launch of a capital increase with preferential subscription rights for a maximum amount of approximately €1.1 million
Published on 09/01/2026 at 19:00, 7 hours 2 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 09/01/2026 at 18:18, 7 hours 44 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - August 2026
Published on 09/01/2026 at 17:44, 8 hours 18 minutes ago Reporting on share buyback transactions carried out between August 18 and August 28, 2026
Published on 09/01/2026 at 17:39, 8 hours 23 minutes ago Disclosure of transactions in own shares of 31 August, 2026
Published on 08/31/2026 at 17:45, 1 day 8 hours ago Disclosure of transactions in own shares from August 24 to August 28, 2026
